Meta-analysis of the efficacy and safety of tripterygium glycosides versus RAAS blockers in the treatment of diabetic kidney disease

Meta-analysis of the efficacy and safety of tripterygium glycosides versus RAAS blockers in the treatment of diabetic kidney disease

Objective To evaluate the efficiency and safety of tripterygium glycosides(TG) in the treatment of diabetic kidney disease compared with RAAS blockers. Methods Meta-analysis of retrieved results and data was performed through CNKI, CBM, VIP, Wanfang data, Embase, Pubmed, and Cochrane Library databas...

Full description

Saved in:

Bibliographic Details
Main Authors:	ZHU Guo-shuang, WANG Lan, LONG Qing-hua, JIN Shan-shan, SUN Long, LI ying-xia, DENG dan-fang, LIN La-mei, WANG xiao-qin
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2019-01-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Tripterygium glycosides Diabetic kidney disease Meta-analysis Reninangiotensin-aldosterone system blocker
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57910595&Fpath=home&index=0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meta-analysis of efficacy and safety of multi-glycoside of Tripterygium wilfordii in the treatment of idiopathic membranous nephropathy
by: YIN Song-jiang, et al.
Published: (2016-01-01)

Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
by: Bidan Zheng, et al.
Published: (2023-12-01)

Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
by: Zhuan’E. Yao, et al.
Published: (2025-01-01)

Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis
by: GUO Bo-hui, et al.
Published: (2019-01-01)

A network Meta-analysis of tripterygium wilfordii polyglycosides tablet,ambrette capsule and RAS blocker in the treatment of IgA nephropathy
by: FANG Xin-ying, et al.
Published: (2020-01-01)

Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials
by: Yaotan Li, et al.
Published: (2025-07-01)

The Lnc‐ENST00000602558/IGF1 axis as a predictor of response to treatment with tripterygium glycosides in rheumatoid arthritis patients
by: Yang Gao, et al.
Published: (2024-01-01)

Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides
by: Xu Fangdan, et al.
Published: (2025-01-01)

Vitamin D role in arterial hypertension development
by: E. N. Dudinskaya, et al.
Published: (2012-06-01)

Research on nanoemulsion for increasing effects and reducing toxicity of Tripterygium wilfordii polyglycosides
by: HE Xin, et al.
Published: (2008-05-01)

Progress on Tripterygium wilfordii Hook f. as a treatment option for neurodegenerative diseases
by: Zhong-mou Zhang, et al.
Published: (2024-12-01)

Genome-wide characterization and expression analysis of WRKY family genes in the biosynthesis of triptolide in Tripterygium wilfordii
by: Limei Tang, et al.
Published: (2025-04-01)

Therapeutic effects and mechanisms of Tripterygium wilfordii extracts in rheumatoid arthritis: a systematic review and meta-analysis of preclinical studies
by: Kai Chen, et al.
Published: (2025-07-01)

The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applications
by: Zhonghao Liu, et al.
Published: (2025-07-01)

Structure Characterization of Four New Sesquiterpene Pyridine Alkaloids from <i>Tripterygium wilfordii</i> Hook. f. and Anti-Inflammatory Activity Evaluations
by: Yong-Jian Wang, et al.
Published: (2024-11-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
by: Yaqi Cheng, et al.
Published: (2024-12-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

Efficacy of Shenkang Injection combined with renin-angiotensin-aldosterone system blockers in diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
by: Xinyue Zhang, et al.
Published: (2025-12-01)

Pharmacological aspects of acute treatment glycoside intoxication
by: M. I. Sperling, et al.
Published: (2021-08-01)

3′-Caffeoylquercetin Glycosides and 4′-Caffeoylkaempferol Glycosides—Novel Antioxidant Flavonoids Discovered in the Freesia Yellow Flowers
by: Kazutoshi Shindo, et al.
Published: (2025-01-01)

The Impact of Beta-Blockers and Renin-Angiotensin-Aldosterone System Inhibitors on the Prognosis of Atrial Fibrillation Patients with Chronic Obstructive Pulmonary Disease: A Nation-Wide Registry Study
by: Liang H, et al.
Published: (2025-03-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

SPIROSTAN GLYCOSIDES FROM TRIBULUS TERRESTRIS
by: Nguyen Van Quoc*, et al.
Published: (2025-06-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)

Progress on Synthetic Biology for Steviol Glycosides Biosynthesis
by: Mengyu LIU, et al.
Published: (2025-03-01)

Bioactive Xanthone C-glycoside Derivatives – QSAR Approach
by: V. N. Aksenova, et al.
Published: (2023-05-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

ACUTE INTAKE OF A LARGE DOSE OF CARDIAC GLYCOSIDES BY A YOUNG MALE
by: L. Savchenko, et al.
Published: (2017-03-01)

Efficacy and harms associated with β-blockers for cardiotoxicity in cancer patients undergoing chemotherapy: a systematic review and meta-analysis
by: Jessica T. Li, et al.
Published: (2024-06-01)

Synthesis of pyranopyrazolo N-glycoside and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial agents
by: Hafez Hend N., et al.
Published: (2015-09-01)

Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
by: Yu-qiong Lin, et al.
Published: (2024-12-01)

Beta blockers and their combinations in the management of hypertension
by: J.A. Ker
Published: (2012-10-01)

BIOLOGICAL ACTIVITY OF STEROIDAL GLYCOSIDES FROM BULBS OF ALLIUM CYRILLII TEN. (ALLIACEAE)
by: N. V. Tolkachova, et al.
Published: (2015-09-01)

Characterization of glycoside hydrolases involved in xyloglucan degradation in the thermophilic bacterium Thermotoga maritima
by: Yuzuki Kawai, et al.
Published: (2025-06-01)

Enzymatic Glycosylation of <i>Ganoderma</i> Terpenoid via Bacterial Glycosyltransferases and Glycoside Hydrolases
by: Te-Sheng Chang, et al.
Published: (2025-05-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

N-Glycosides of indigo, indirubin, and isoindigo: blue, red, and yellow sugars and their cancerostatic activity
by: Peter Langer
Published: (2024-11-01)

Effects of pollen patties with curcumin-steviol glycoside complex on Apis mellifera
by: Sehyun Park, et al.
Published: (2025-03-01)